Petrak, R. M., Skorodin, N. C., Van Hise, N. W., Fliegelman, R. M., Pinsky, J., Didwania, V., Anderson, M., Diaz, M., Shah, K., Chundi, V. V., Hines, D. W., Harting, B. P., Sidwha, K., Yu, B., Brune, P., Owaisi, A., Beezhold, D., Kent, J., Vais, D., Han, A., Gowda, N., Sahgal, N., Silverman, J., Stake, J., Nepomuceno, J., & Heddurshetti, R. (2021). tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS‐CoV‐2. Clinical and translational science, 14(6), 2146–2151. http://access.bl.uk/ark:/81055/vdc_100146093414.0x000011